Gene · 8784
Papers4,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 4,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell transcriptomics reveals heterogeneity in esophageal squamous epithelial cells and constructs models for predicting patient prognosis and immunotherapy. | Front Immunol | 2023 | 38098487 | PubTator, text mining | PubMed |
| Killer instincts: natural killer cells as multifactorial cancer immunotherapy. | Front Immunol | 2023 | 38090565 | PubTator, text mining | PubMed |
| Investigating the crosstalk between chronic stress and immune cells: implications for enhanced cancer therapy. | Front Neurosci | 2023 | 38089966 | PubTator, text mining | PubMed |
| Intragraft regulatory T cells in the modern era: what can high-dimensional methods tell us about pathways to allograft acceptance? | Front Immunol | 2023 | 38077395 | PubTator, text mining | PubMed |
| Editorial: Community series in the role of angiogenesis and immune response in tumor microenvironment of solid tumor: volume II. | Front Immunol | 2023 | 38077341 | PubTator, text mining | PubMed |
| FANCI serve as a prognostic biomarker correlated with immune infiltrates in skin cutaneous melanoma. | Front Immunol | 2023 | 38077326 | PubTator, text mining | PubMed |
Expansion of CD4+ cytotoxic T lymphocytes with specific gene expression patterns may contribute to suppression of tumor immunity in oral squamous cell carcinoma: single-cell analysis and in vitro experiments. | Front Immunol | 2023 | 38077321 | PubTator, text mining | PubMed |
| Histone ubiquitination-related gene CUL4B promotes lung adenocarcinoma progression and cisplatin resistance. | Front Genet | 2023 | 38075690 | PubTator, text mining | PubMed |
| TPD52L2 as a potential prognostic and immunotherapy biomarker in clear cell renal cell carcinoma. | Front Oncol | 2023 | 38074636 | PubTator, text mining | PubMed |
| Pre-treatment inflamed tumor immune microenvironment is associated with FOLFIRINOX response in pancreatic cancer. | Front Oncol | 2023 | 38074633 | PubTator, text mining | PubMed |
| Hypofractionation in Glioblastoma: An Overview of Palliative, Definitive, and Exploratory Uses. | Cancers (Basel) | 2023 | 38067354 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing in cancer research: discovering novel biomarkers and therapeutic targets for immune checkpoint blockade. | Cancer Cell Int | 2023 | 38066642 | PubTator, text mining | PubMed |
| Dynamic profiling of immune microenvironment during anti-PD-1 immunotherapy for head and neck squamous cell carcinoma: the IPRICE study. | BMC Cancer | 2023 | 38066522 | PubTator, text mining | PubMed |
| A novel endoplasmic reticulum stress-related lncRNA signature for prognosis prediction and immune response evaluation in Stomach adenocarcinoma. | BMC Gastroenterol | 2023 | 38066437 | PubTator, text mining | PubMed |
| Immune checkpoints are predominantly co-expressed by clonally expanded CD4+FoxP3+ intratumoral T-cells in primary human cancers. | J Exp Clin Cancer Res | 2023 | 38057799 | PubTator, text mining | PubMed |
| Molecular Biomarkers in Thyroid Eye Disease: A Literature Review. | Ophthalmic Plast Reconstr Surg | 2023 | 38054982 | PubTator, text mining | PubMed |
| Identification and validation of 5-methylcytosine-associated genes in diffuse large B-cell lymphoma. | Heliyon | 2023 | 38045198 | PubTator, text mining | PubMed |
| Harnessing T cell exhaustion and trogocytosis to isolate patient-derived tumor-specific TCR. | Sci Adv | 2023 | 38039364 | PubTator, text mining | PubMed |
| An association between ATP7B expression and human cancer prognosis and immunotherapy: a pan-cancer perspective. | BMC Med Genomics | 2023 | 38037104 | PubTator, text mining | PubMed |
| GITR activation ex vivo impairs CD8 T cell function in people with HIV on antiretroviral therapy. | iScience | 2023 | 38026168 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8784/papers?page=13